Cargando…
HER2 drives Mucin-like 1 to control proliferation in breast cancer cells
Mucin-like 1 (MUCL1) was first identified as a breast-specific gene over a decade ago. Based on its highly restricted mRNA expression in breast tissue and continued expression during breast tumorigenesis and progression, MUCL1 is an attractive tumor-associated antigen and a potential therapeutic tar...
Autores principales: | Conley, S J, Bosco, E E, Tice, D A, Hollingsworth, R E, Herbst, R, Xiao, Z |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996539/ https://www.ncbi.nlm.nih.gov/pubmed/26725324 http://dx.doi.org/10.1038/onc.2015.487 |
Ejemplares similares
-
Her-2 positive mucinous carcinoma breast cancer, case report
por: Garcia Hernandez, Irean, et al.
Publicado: (2017) -
Clinicopathologic characteristics of HER2-positive pure mucinous carcinoma of the breast
por: Jang, Yunjeong, et al.
Publicado: (2020) -
An evaluation of mucin-like carcinoma associated antigen (MCA) in breast cancer.
por: Cooper, E. H., et al.
Publicado: (1989) -
Use of mucin like cancer associated antigen (MCA) in the management of breast cancer.
por: Laurence, V., et al.
Publicado: (1991) -
Pleomorphic Invasive Lobular Carcinoma of the Breast With
Extracellular Mucin and HER2 Amplification
por: Burky, Matthew J, et al.
Publicado: (2020)